Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsuo Taniguchi

Showing results (121-130 of 150) with videos related to

Pageof 15
Sort By:
Modern Rheumatology|July 30, 2016
Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in JapanEiichi Tanaka, Eisuke Inoue, Rei Yamaguchi, et al.
The Journal of Rheumatology|February 9, 2018
<i>HLA-DRB1</i> Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide AntibodiesRyosuke Hiwa, Katsunori Ikari, Koichiro Ohmura, et al.
Modern Rheumatology|January 27, 2015
Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012Eri Sato, Eiichi Tanaka, Moeko Ochiai, et al.
Modern Rheumatology|June 9, 2015
Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA databaseDaisuke Hoshi, Eiichi Tanaka, Ataru Igarashi, et al.
Kidney International|April 17, 2004
Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese familiesEiji Kudo, Naoyuki Kamatani, Osamu Tezuka, et al.
Modern Rheumatology|October 18, 2012
No increased mortality in patients with rheumatoid arthritis treated with biologics: results from the biologics register of six rheumatology institutes in JapanAyako Nakajima, Kazuyoshi Saito, Toshihisa Kojima, et al.
Journal of Medical Genetics|October 14, 2017
Genetic landscape of interactive effects of <i>HLA-DRB1</i> alleles on susceptibility to ACPA(+) rheumatoid arthritis and ACPA levels in Japanese populationChikashi Terao, Yukinori Okada, Katsunori Ikari, et al.
Modern Rheumatology|February 21, 2008
Therapeutic efficacy of intravenous cyclophosphamide concomitant with moderate- to high-dose prednisolone in two patients with fasciitis panniculitis syndromeTakashi Kato, Ayako Nakajima, Makoto Soejima, et al.
Arthritis Care & Research|June 20, 2014
Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult populationChikashi Terao, Koichiro Ohmura, Katsunori Ikari, et al.
Modern Rheumatology|January 5, 2016
A twin study of rheumatoid arthritis in the Japanese populationChikashi Terao, Katsunori Ikari, Shingo Nakayamada, et al.
Pageof 15

Showing results (121-130 of 150) with videos related to

Sort By:
Pageof 15
Modern Rheumatology|July 30, 2016
Pharmacoeconomic analysis of biological disease modifying antirheumatic drugs in patients with rheumatoid arthritis based on real-world data from the IORRA observational cohort study in JapanEiichi Tanaka, Eisuke Inoue, Rei Yamaguchi, et al.
The Journal of Rheumatology|February 9, 2018
<i>HLA-DRB1</i> Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide AntibodiesRyosuke Hiwa, Katsunori Ikari, Koichiro Ohmura, et al.
Modern Rheumatology|January 27, 2015
Chronological changes in baseline disease activity of patients with rheumatoid arthritis who received biologic DMARDs between 2003 and 2012Eri Sato, Eiichi Tanaka, Moeko Ochiai, et al.
Modern Rheumatology|June 9, 2015
Profiles of EQ-5D utility scores in the daily practice of Japanese patients with rheumatoid arthritis; Analysis of the IORRA databaseDaisuke Hoshi, Eiichi Tanaka, Ataru Igarashi, et al.
Kidney International|April 17, 2004
Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese familiesEiji Kudo, Naoyuki Kamatani, Osamu Tezuka, et al.
Modern Rheumatology|October 18, 2012
No increased mortality in patients with rheumatoid arthritis treated with biologics: results from the biologics register of six rheumatology institutes in JapanAyako Nakajima, Kazuyoshi Saito, Toshihisa Kojima, et al.
Journal of Medical Genetics|October 14, 2017
Genetic landscape of interactive effects of <i>HLA-DRB1</i> alleles on susceptibility to ACPA(+) rheumatoid arthritis and ACPA levels in Japanese populationChikashi Terao, Yukinori Okada, Katsunori Ikari, et al.
Modern Rheumatology|February 21, 2008
Therapeutic efficacy of intravenous cyclophosphamide concomitant with moderate- to high-dose prednisolone in two patients with fasciitis panniculitis syndromeTakashi Kato, Ayako Nakajima, Makoto Soejima, et al.
Arthritis Care & Research|June 20, 2014
Effects of smoking and shared epitope on the production of anti-citrullinated peptide antibody in a Japanese adult populationChikashi Terao, Koichiro Ohmura, Katsunori Ikari, et al.
Modern Rheumatology|January 5, 2016
A twin study of rheumatoid arthritis in the Japanese populationChikashi Terao, Katsunori Ikari, Shingo Nakayamada, et al.
Pageof 15